Before the advent of pulmonary arterial catheter two distinct clinical profiles of septic shock had been described [1, 2]. One was characterized by warm, dry skin and a bounding pulse despite hypotension (“warm” shock) and the other by cold skin (“cold” shock). Authors were under the impression that “warm” shock was seen in the initial phase of hospitalization in septic shock patients while “cold” shock was more often observed later, before patients died. Invasive measurements were available in few patients showing that “warm” shock was associated with high cardiac output (CO) and “cold” shock with a low CO (Fig. 1a). It was then concluded that patients in septic shock initially went through an early hyperdynamic phase after the onset of illness and eventually either recovered or deteriorated into heart failure or myocardial depression related to sepsis leading to hypodynamic shock and death [3]. The latter concept was supported by animal models designed by Weil (Fig. 2) using intravenous bolus injections of high doses of endotoxin or live organisms [4, 5] (Fig. 1b), showing septic shock characterized by reduced CO and elevated systemic vascular resistance (SVR) leading to animal death (Fig. 1b).